Arrhythmia
Conditions
Brief summary
The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.
Interventions
DEVICENormal treatment with catheter ablation or medicine
Routine clinical care with catheter ablation and/or medicine; real-world clinical cases
DRUGDrug Treatment
Routine clinical care with medicine; real-world clinical cases
Sponsors
Beijing Anzhen Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Inclusion criteria
* Patients hospitalized for any type of arrhythmia
Exclusion criteria
* Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Arrhythmia recurrence | 1 year | Recurrence of the arrhythmia after treatment |
| All-cause death | 1 year | Death due to any reason |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Arrhythmia recurrence | 5 year | Recurrence of the arrhythmia after treatment |
| Heart failure | 1 year | Heart failure due to cardiovascular disease |
| Cardiovascular death | 1 year | Death due to cardiovascular disease |
| All-cause death | 5 year | Death due to any reason |
| Cardiovascular hospitalization | 1 year | Hospitalization due to cardiovascular disease |
Countries
China
Outcome results
None listed